Maternal Placental Growth Factor (PlGF) levels, sonographic placental parameters, and outcomes of IVF pregnancies with and without embryo trophectoderm biopsy
Journal of Assisted Reproduction and Genetics · 2024
DOI: 10.1007/s10815-024-03193-8 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Assisted Reproduction and Genetics, 2024. Verfasst von John W Snelgrove und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics & Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, Canada. john.snelgrove@sinaihealth.ca. Hauptthemen laut MEDLINE: Placenta Growth Factor, Fertilization in Vitro, Placenta, Pregnancy Outcome. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
PURPOSE: In vitro fertilization (IVF) is associated with abnormal trophoblast invasion and resultant decreased levels of circulating placental biomarkers such as placental growth factor (PlGF). Our objective was to evaluate maternal serum levels of second/third trimester PlGF, sonographic placental parameters, and clinical outcomes among IVF frozen embryo transfer (FET) pregnancies with and without embryo trophectoderm biopsy. METHODS: This was a retrospective study of pregnant patients who conceived using a single frozen embryo transfer (FET) and gave birth between 30 January 2018 and 31 May 2021. We compared PlGF levels, sonographic placental parameters, and clinical outcomes between FET with biopsy and FET without biopsy groups. RESULTS: The median PlGF level was 614.5 pg/mL (IQR 406-1020) for FET pregnancies with biopsy, and 717.0 pg/mL (IQR 552-1215) for FET pregnancies without biopsy. The adjusted mean difference was 190.9 pg/mL lower in the FET biopsy group (95% CI, -410.6, 28.8; p = 0.088). There were no statistically significant differences in placental parameters or clinical pregnancy outcomes. CONCLUSION: This exploratory study demonstrated a possible trend toward lower maternal serum PlGF in the pregnancies conceived with FET using a biopsied embryo. Further investigation is warranted into the potential placental health effects of trophectoderm biopsy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Obstetrics & Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, Canada. john.snelgrove@sinaihealth.ca.
- Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, Canada. john.snelgrove@sinaihealth.ca.
- Department of Family and Community Medicine, Women's College Hospital, University of Toronto, Toronto, Canada.
- Department of Medicine, University of Toronto, Toronto, Canada.
- Department of Obstetrics & Gynaecology, Mount Sinai Hospital, University of Toronto, Toronto, Canada.
- Department of Laboratory Medicine & Pathobiology, University of Toronto, Toronto, Canada.
Zitieren
APA
Snelgrove, J. W., Lee, R., Jeyakumar, Y., Greenblatt, E. M., Kingdom, J. C., Zwingerman, R., & McLaughlin, K. (2024). Maternal Placental Growth Factor (PlGF) levels, sonographic placental parameters, and outcomes of IVF pregnancies with and without embryo trophectoderm biopsy. Journal of Assisted Reproduction and Genetics. https://doi.org/10.1007/s10815-024-03193-8
Vancouver
Snelgrove JW, Lee R, Jeyakumar Y, Greenblatt EM, Kingdom JC, Zwingerman R, et al. Maternal Placental Growth Factor (PlGF) levels, sonographic placental parameters, and outcomes of IVF pregnancies with and without embryo trophectoderm biopsy. Journal of Assisted Reproduction and Genetics. 2024. doi:10.1007/s10815-024-03193-8
BibTeX
@article{Snelgrove2024,
author = {Snelgrove, John W and Lee, Rachel and Jeyakumar, Yaanu and Greenblatt, Ellen M and Kingdom, John C and Zwingerman, Rhonda and McLaughlin, Kelsey},
title = {Maternal Placental Growth Factor (PlGF) levels, sonographic placental parameters, and outcomes of IVF pregnancies with and without embryo trophectoderm biopsy},
journal = {Journal of Assisted Reproduction and Genetics},
year = {2024},
doi = {10.1007/s10815-024-03193-8}
}
EUVIMED